Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype - Concepedia

Concepedia

Publication | Closed Access

Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype

63

Citations

35

References

2015

Year

Kuo‐Wang Tsai, Guancheng Li, Chien‐Hsun Chen, Ming-Hsin Yeh, Jer‐Shyung Huang, Hui‐Hwa Tseng, Ting‐Ying Fu, Huei‐Han Liou, Hung‐Wei Pan, Shengfeng Huang,

Breast Cancer Research and Treatment

Breast OncologyOncologyBreast Cancer PatientsMedicineBreast CancerAnti-cancer AgentEr/pr-negative SubtypePharmacologyRadiation OncologyPoor Prognostic FactorEndocrine-related Cancer

References

	Year	Citations

Page 1

Page 1